{"id":7861,"date":"2007-09-11T23:59:00","date_gmt":"2007-09-11T23:59:00","guid":{"rendered":"https:\/\/bm.dev.synology.me\/?p=7861"},"modified":"2026-04-02T10:15:30","modified_gmt":"2026-04-02T10:15:30","slug":"spre-europa-via-bulgaria","status":"publish","type":"post","link":"https:\/\/bm.dev.synology.me\/?p=7861","title":{"rendered":"Spre Europa, via Bulgaria"},"content":{"rendered":"<p><P style=\"MARGIN: 0cm 0cm 0pt\"><SPAN lang=PT-BR style=\"mso-ansi-language: PT-BR\">Compania indiana Elder Pharmaceuticals a cumparat 51% din actiunile producatorului bulgar de medicamente Biomeda Group. Pretul platit a fost de aproape 5 milioane de euro. <\/SPAN><SPAN style=\"mso-ansi-language: IT\">Firma bulgara se situeaza intre primii zece producatori si distribuitori de produse farmaceutice din tara. <\/SPAN><\/P><SPAN style=\"mso-ansi-language: IT\"><SPAN>  <P>&nbsp;<\/P>  <P><SPAN style=\"mso-ansi-language: IT\"><\/SPAN><SPAN lang=PT-BR style=\"mso-ansi-language: PT-BR\">Anul trecut, compania a inregistrat o cifra de afaceri de peste 10 milioane de euro. <\/SPAN><SPAN style=\"mso-ansi-language: IT\">Alok Saxena, directorul Elder Pharmaceuticals, spune ca achizitia constituie un vehicul de intrare pe piata bulgara si un mijloc de a patrunde pe toate pietele importante din Europa. Elder Pharmaceuticals isi propune sa ajunga un actor semnificativ pe piata medicamentelor prin intarirea prezentei pe pietele din Europa, Asia Pacific si America Latina. <\/SPAN><SPAN lang=PT-BR style=\"mso-ansi-language: PT-BR\">Recent, firma a achizitionat si compania britanica NeutraHealth, furnizor de suplimente nutritive.<\/SPAN><\/P><\/SPAN><\/SPAN><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Compania indiana Elder Pharmaceuticals a cumparat 51% din actiunile producatorului bulgar de medicamente Biomeda Group. Pretul platit a fost de aproape 5 milioane de euro. Firma bulgara se situeaza intre primii zece producatori si distribuitori de produse farmaceutice din tara. <\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[510],"tags":[632],"class_list":["post-7861","post","type-post","status-publish","format-standard","hentry","category-actualitate","tag-actualitate"],"_links":{"self":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/7861","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=7861"}],"version-history":[{"count":1,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/7861\/revisions"}],"predecessor-version":[{"id":29098,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=\/wp\/v2\/posts\/7861\/revisions\/29098"}],"wp:attachment":[{"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=7861"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=7861"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bm.dev.synology.me\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=7861"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}